Evaluation of self-care activities and quality of life in patients with type 2 diabetes treated with metformin using the 2d matrix code of outer drug packages as patient identifier: the depro proof-of-concept observational study

HIGHLIGHTS

• who: Unknown from the Germany Germany have published the research: Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study, in the Journal: (JOURNAL)
• what: The aim of the DePRO study was to assess the feasibility of a fully digital data-capture workflow the authentication of participants via drug packaging 2D matrix codes in patients with type 2 diabetes mellitus (T2DM) who use metformin. The aim was to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.